Belite Bio (BLTE) EV to EBITDA (2022 - 2026)

Belite Bio (BLTE) EV to EBITDA (2022 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EV to EBITDA
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -925.78
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -570,648.79
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -154,826.82
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -148,087.45
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -46,794.65
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -281,892.54
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 22.98
9 Abivax 91.96 Bn 91.96 Bn - -310.38
10 Regeneron Pharmaceuticals 63.43 Bn 54.67 Bn 3.31 Bn 12.41

Historic Data

Download Data
DateValue
Jun 18, 2026 -925.78
Jun 17, 2026 -935.90
Jun 16, 2026 -873.99
Jun 15, 2026 -913.26
Jun 12, 2026 -874.56
Jun 11, 2026 -873.20
Jun 10, 2026 -871.02
Jun 9, 2026 -894.16
Jun 8, 2026 -882.14
Jun 5, 2026 -906.49
Jun 4, 2026 -913.51
Jun 3, 2026 -867.79
Jun 2, 2026 -857.36
Jun 1, 2026 -57.38
May 29, 2026 -56.25
May 28, 2026 -57.90
May 27, 2026 -55.35
May 26, 2026 -54.92
May 22, 2026 -53.27
May 21, 2026 -0.06